Hepatic encephalopathy (HE) is a major problem in patients treated with TIPS. The aim of the study was to establish whether pre-TIPS covert HE is an independent risk factor for the development of HE after TIPS.
INTRODUCTION
Transjugular intrahepatic portosystemic shunt (TIPS) is currently used for the treatment of complications of portal hypertension, mainly variceal rebleeding and refractory ascites (1) (2) (3) (4) (5) (6) (7) (8) (9) . Th is procedure involves a major drawback: hepatic encephalopathy (HE). Th is complication has been reported in 30-55% ( 10-15 ) of cirrhotic patients within the fi rst year, and up to 10% of patients treated with a TIPS may experience a severe form of HE that is refractory to standard treatments and will need to be resolved by reducing the shunt diameter ( 13 ) . Unfortunately, no pharmacological treatment has yet proved to be able to reduce the incidence of post-TIPS HE. Th e only randomized controlled trial carried out with this aim failed to show any benefi cial eff ect of drugs commonly used in the treatment of HE ( 16 ) . More recently, a randomized controlled trial was performed to assess the effi cacy of polytetrafl uoroethylene-covered stents of diff erent diameters (10 vs. 8 mm) on the incidence of post-TIPS HE. Unfortunately, the trial was stopped because the stents with the smaller diameter were unable to control the complications of portal hypertension ( 17 ) . Th us, the selection of patients remains the only method to try to reduce the incidence of post-TIPS HE, and many studies have attempted to identify the predictors of this complication in order to select for TIPS only those patients with the lowest incidence. Th e factors identifi ed as the most robust predictors of , Manuela Merli , MD 1 , Filippo Maria Salvatori , MD 1 , 3 , Leandra Nikolli , MD 1 post-TIPS HE were previous HE, age, a low porto-caval pressure gradient, and a high Child-Pugh score ( 13, (18) (19) (20) . Further factors were high creatinine levels ( 13 ) and low serum sodium concentration ( 21 ) . Despite the exclusion of patients with previous HE and advanced liver disease, the incidence of post-TIPS HE still remains fairly high ( 22 ) ; thus, other factors are involved.
In cirrhotic patients without TIPS, the presence of subclinical cognitive impairment, also known as covert HE ( 23 ) , has been shown to be a strong predictor of the occurrence of overt HE ( 24 ) . Correspondingly, alterations in psychometric performance detected in a TIPS candidate before the procedure may help identify the patients at risk of HE aft er the procedure. Actually, in our randomized controlled trial ( 16 ) , post-TIPS HE developed more frequently in patients with an abnormal psychometric test (Trail Making Test A) before TIPS, and, more recently, Berlioux P. et al. showed in 54 patients submitted to a TIPS that the incidence of HE increased in those with abnormal critical fl icker frequency before a TIPS ( 25 ) . However, in both studies, the relationship between psychometric performance and post-TIPS HE was present only at the univariate analysis, and thus the role of cognitive impairment as a risk factor for HE aft er a TIPS remains uncertain.
Th e aim of the present study was to establish whether pre-TIPS covert HE is an independent risk factor for the development of HE and whether the psychometric evaluation before a TIPS may be used for selecting patients in order to have the lowest rate of HE aft er a TIPS.
METHODS
From January 2011 to December 2014, all consecutive cirrhotic patients undergoing TIPS were considered eligible for the study. In our Center, exclusion criteria for TIPS placement are age >75 years, bilirubin levels >5 mg/dl, creatinine levels >3 mg/dl, a serious cardiac or pulmonary dysfunction, a Child-Pugh's score >11 (except for patients who were candidates for early TIPS), a model end-stage liver disease score >18, the presence of portal thrombosis, a diagnosis of hepatic carcinoma, sepsis, and spontaneous bacterial peritonitis. Present HE or previous spontaneous/recurrent HE is also a contraindication to TIPS; however, patients with only one episode of HE precipitated by variceal bleeding and ameliorated aft er the bleeding was controlled are not excluded. Other exclusion criteria were alcohol/psychoactive drugs intake (positive alcoholaemia and/or benzodiazepines or opioid urine metabolites) at the moment of evaluation, unrelated neurological disease including dementia (mini mental state <26), and lack of compliance with psychometric evaluation because of language barriers or reduced visual acuity.
Th e purpose of the study, the enrollment, and the details of the TIPS operation were clearly explained to all the patients before obtaining their written informed consent. Th e "Sapienza" University of Rome Ethical Committee approved the collection of data of the patients for prognostic studies (Rif.1720/01.10.09).
All TIPS procedures were carried out by the same radiology team, using polytetrafl uoroethylene-covered stents of 10 mm diameter. Th e anesthesiological procedure ( 4, 26 ) and the technical details of TIPS with polytetrafl uoroethylene-covered stent-graft implantation were previously described ( 27, 28 ) . All the subjects were evaluated and followed by the same medical team by a prospective protocolled diagnostic work-up and a surveillance strategy.
Th e day before the procedure, a basal evaluation of HE, including an examination and grading of the patients' mental state, asterixis, and psychometric performance, as well as the determination of venous blood ammonia, were carried out. Th e evaluation of the degree of HE was based on the alteration of the patient's mental state using modifi cations of the West Haven Criteria ( 29 ) . Th e mental state was assessed in each patient by the same investigator using standardized tests and questions, as previously described ( 30 ) . All patients also underwent the psychometric HE score (PHES) battery of tests, including the digit-symbol-test, the trail-making-test A and B, the serial-dotting-test, and the line-tracing-test. Each test was scored against age and education-adjusted norms for the Italian population. Th e PHES is the sum of integer scores of each test computed from the adjusted Z-values, as follows: score=−3 for Z ≤−3, score −2 for −3< Z ≤−2, score −1 for −2< Z ≤−1, score 0 for −1< Z <1, score 1 for Z ≥1. Th e PHES ≤−4 was considered abnormal ( 30 ) . Blood samples from a peripheral vein were collected in iced tubes for the determination of ammonia, which was performed immediately aft er using the Ammonia Checker II (Menarini, Florence, Italy), as previously described ( 31 ) .
None of the patients received any pharmacological treatment to prevent the occurrence of HE. Aft er TIPS, the patients remained hospitalized for 1 week and then were followed up once a week in the outpatient department for the fi rst month. Th e patients were then seen every 3 months and also contacted by phone every month for the fi rst 6 months. Th ereaft er, the patients were seen every 6 months. Moreover, both the patients and their families were instructed about the importance of an immediate contact with the medical staff should any alteration in their mental state occur between the scheduled visits. In particular, the family was instructed to refer the occurrence of lethargy, apathy, obvious personality changes, inappropriate behavior, or disorientation to time and space (corresponding to a grade-II alteration of the patients' mental state). In this case, the HE evaluation, including the psychometric performance, was repeated to confi rm and stage the degree of HE. A grade II HE or higher was considered an episode of overt HE ( 23 ) , and the patients were censored as HE+ patients. Th e occurrence of a recurrent HE (defi ned as at least three episodes of non precipitant-induced severe encephalopathy requiring hospitalization in the last 3 months despite continuous treatment with non-absorbable disaccharides) or a persistent HE (defi ned as the presence of a continuously detectable altered mental state with further episodic deterioration despite protein restriction and treatment with non-absorbable disaccharides) was also recorded, and the patients were considered aff ected by refractory HE. Th ose patients with an overt episode of HE were then managed either as in-or outpatients, depending on the severity of the HE episode. Once developed, HE was treated with the oral administration of non-absorbable disaccharides or non-absorbable antibiotics. All potential HE precipitating events were treated and, when possi-
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Statistical analysis
Th e data are reported as mean±s.d. Comparisons between groups were performed by unpaired Student's t -test or χ 2 -test. We estimated the cumulative incidence of the fi rst episode of HE during the fi rst 6 months of follow up, taking into account the nature of the competing risks in the data (HE before LT, death, and LT are competing events). As the study is estimating outcomes other than all-cause mortality, a method based on multistate disease models was selected. Th e usual Cox regression model in this context might be severely biased ( 32 ) and the sub-distribution model of Fine and Gray was selected. Th e conditional sub-distribution hazard at multivariate analysis was evaluated using the model of Fine and Gray ( 33 ) . We therefore report on the sub-distribution hazard ratios (sHRs) rather than the usual HR, but the former have similar interpretations to the latter. Th e factors associated with the development of HE were initially evaluated by univariate models (using univariate Fine and Gray models) and then included in a multivariate analysis (according to multivariate Fine and Gray models). Th e fi nal multivariate model was chosen in a forward manner by minimizing the Bayesian Information Criterion.
In order to build a score for the prediction of HE post TIPS, we built an event-history analysis model allowing for competing risks, therefore predicting the risk of the event. Th e maximum likelihood coeffi cients of the optimal model were used as weights for the new score. A time-dependent ROC curve ( 34 ) for censored data at 6 months of follow-up was estimated using the NN estimation method, whereas signifi cance tests and confi dence intervals were assessed through the non-parametric bootstrap. Sensitivity, specifi city, positive predictive value, and negative predictive value were based on the estimated relative operating characteristic at 6 months. Soft ware R version 3.0.2 (Stanford University, CA) was used for all computations.
RESULTS
Th e demographic, clinical, and biochemical characteristics of the patients are reported in Table 1 .
During the whole follow-up, 35 of the 82 (43%) patients developed at least one episode of overt HE. In 3 of them, HE persisted and was refractory to standard treatment, needing the reduction in the stent calibre to ameliorate. Th is procedure was carried out 5, 6, and 8 months aft er TIPS and led to the resolution of HE symptoms in all patients. During the whole follow-up, 13 patients died and 5 were transplanted.
Th e comparison between the 35 patients with overt HE and the 47 patients who did not develop HE aft er a TIPS is reported in Table 2 . At the time of the TIPS placement, there were no significant diff erences between the two groups in gender, etiology and severity of liver disease (Child-Pugh and model end-stage liver disease score) and most biochemical parameters. However, age (55 vs. 62 years) was signifi cantly higher and serum sodium (138 vs. 135 mEq/ml) signifi cantly lower in patients with post-TIPS HE. Th e porto-systemic gradient measured immediately aft er the shunt opening was 6.9±3.9 in the HE patient group and 5.9±3.2 in the patients who did not develop HE aft er a TIPS (NS). In the group of patients with HE aft er a TIPS, there was a higher prevalence of patients in whom TIPS was indicated because of refractory ascites, but the diff erence did not reach statistical signifi cance ( P =0.08). As far as the pre-TIPS evaluation of the patients' cognitive function is concerned, according to our exclusion criteria, no patients had signs of HE at inclusion and only a few of them (11 patients, 13%) experienced one episode of precipitated HE before a TIPS.
Seventy-seven percent of the patients with post-TIPS HE were classifi ed as aff ected by covert HE before a TIPS according to the PHES evaluation. Th e corresponding fi gure in the group without HE was 32% and the diff erence was highly signifi cant ( P =0005). Th e cumulative incidence of HE aft er TIPS, taking into consideration LT and death as risks competing with HE development, is reported in Figure 1 . Th e diff erence in the incidence of post-TIPS HE was highly signifi cant ( P =0.0003) among patients with or without covert HE detected by PHES before a TIPS. Th is diff erence, however, was at the limit of statistical signifi cance, if only the 37 patients operated because of variceal bleeding are considered (58 vs. 28%; P =0.07), whereas it was highly signifi cant in the 45 patients submitted to a TIPS because of refractory ascites (87 vs. 36%; P =0.0001). Moreover, all the 3 patients with refractory HE belonged to the group of ascitic patients. 
DISCUSSION
Th e identifi cation of the risk factors for the development of HE aft er a TIPS is a relevant problem. In fact, post-TIPS HE is very frequent and, although in a minority of patients, it may be persistent and refractory to medical treatment, thus aff ecting deeply the patients' quality of life. Th e problem is, in our opinion, particularly relevant in patients submitted to a TIPS because of refractory ascites. In fact, at variance with the TIPS performed for the prevention of variceal rebleeding, which can be life saving and without therapeutic alternatives, a patient with refractory ascites may be treated with a TIPS or repeated large volume paracentesis with a fairly similar effi cacy at least in terms of survival. Th e lack of preventive measures, whether pharmacological or based on the optimization of the porto-systemic gradient reached aft er the procedure, makes the optimal selection of patients particularly crucial. Previous HE with the exception of that precipitated by variceal bleeding, especially if recidivant, aging and advanced liver failure are the most robust risk factors for post-TIPS HE ( 35 ) , and today most protocols and clinical studies consider the presence of these factors as a contraindication to TIPS. Nevertheless, the incidence of post-TIPS HE continues to be regrettably high, suggesting that other factors may be important.
Th e working hypothesis of the present paper was that the subclinical cognitive impairment, also known as covert HE, may be a predictive factor for overt HE development aft er a TIPS. Th is hypothesis is supported by the fact that covert HE is one of the strongest predictors of the occurrence of overt HE in the follow-up in cirrhotic patients ( 24 ) and by the observation that trail-making-test A, one of the tests included in the PHES, the standard for the identifi cation of patients aff ected by covert HE, as well as the critical fl icker frequency, was signifi cantly correlated with post-TIPS HE at least at univariate analysis. Our results support the hypothesis, as the incidence of post-TIPS HE was signifi cantly diff erent among patients with or without covert HE before a TIPS. Our results are particularly solid because they were obtained in a group of patients already selected for TIPS on the basis of the known risk factors for HE development (see inclusion criteria). Moreover, post-TIPS HE was detected using the PHES, which is considered the standard method ( 23 ) , and statistically analyzed taking into consideration the risks competing with HE during the patients' follow-up ( 32 ), such as death and LT. Finally, at variance with previous observations, covert HE before a TIPS was a predictor independently of a number of clinical and laboratory variables, age and the Child-Pugh score at the multivariate analysis. Th e model derived from the results (including age, Child-Pugh score, and covert HE) showed a fairly good sensitivity and specifi city in identifying patients with overt HE aft er a TIPS. On the basis of the above results, we tried to calculate the possible applicability of the detection of covert HE before a TIPS as a criterion for the selection of patients. If only the results of the PHES evaluation (i.e., not considering age and Child-Pugh score) are taken into consideration, the negative predicting value was 0.80 for all patients and 0.88 for the patients submitted to TIPS because of refractory ascites. Th is means that a patient with refractory ascites, without covert HE according to PHES before a TIPS, has almost 90% probability of being free of HE aft er a TIPS. In our opinion, this observation may help choose the use of TIPS in patients particularly susceptible to severe HE and with treatment alternatives. A limitation of the present observation is inherent to the use of the PHES, which is based on 5 paper and pencil psychometric tests and on Z -scores obtained in a reference population that are available only in Germany, Italy, Spain, India, and Korea. Another limitation of our study is that we were not able to identify the risk factors for refractory HE, which is the most relevant problem in these patients. Th is was due to the fact that, fortunately, only 3 patients developed this complication during the follow-up, limiting the possibility to analyze these data statistically.
In conclusion, the psychometric evaluation before a TIPS is able to identify most of the patients who will develop HE aft er a TIPS and can be useful to select patients in order to have the lowest incidence of this important complication.
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